Ratnakar Securities Pvt. Ltd.

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia

BSE1068.00-8.4 (-0.78 %)

PREV CLOSE ( ) 1076.40

OPEN PRICE ( ) 1089.85

BID PRICE (QTY) 1067.30 (1)

OFFER PRICE (QTY) 1068.20 (1)

VOLUME 606

TODAY'S LOW / HIGH ( )1068.00 1089.85

52 WK LOW / HIGH ( )823.7 1250

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-06 1978

Management Info

Shyam S Bhartia - Chairman Priyavrat Bhartia - Managing Director

Registered Office

Address Bhartiagram ,Jyotiba Phoolay Nagar, ,
Gajraula,
Uttar Pradesh-244223

Phone 05924-267437

Email invstors@jubl.com

Website www.jubilantpharmova.com

Registrars Details

Alankit Assignments Ltd.

205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi

Listing : BSE, NSE

NEWS

02Dec Jubilant Pharmova informs about appoi
Jubilant Pharmova has informed about the appointment of Daniel J. Oâ€™Co..

05Nov Jubilant Pharmovaâ€™s arm gets 9 obser
U.S. Food and Drug Administration (USFDA) has concluded audit at Jubilan..

31Oct Jubilant Pharmova informs about outcom
Pursuant to the provisions of Regulation 33 read with Regulation 30 and..

10Oct Jubilant Pharmova informs about press
Pursuant to Regulation 30 of the Securities and Exchange Board of India..

10Oct Jubilant Pharmovaâ€™s arm launches New
Jubilant Pharmovaâ€™s wholly owned subsidiary -- Jubilant HollisterStier..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	-64	192
Gross Profit	85	376
Operating Profit	126	1317
Net Sales	664	7457

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi Cons. Health (BSE) 4839.95 (4.06%)	M.Cap ( in Cr)10711.54
Albert David (BSE) 790.00 (2.96%)	M.Cap ( in Cr)437.91
Trident Lifeline (BSE) 320.00 (5.54%)	M.Cap ( in Cr)354.68
Ajanta Pharma (BSE) 2650.35 (0.44%)	M.Cap ( in Cr)32967.39
Samrat Pharmachem (BSE) 259.00 (2.25%)	M.Cap ( in Cr)78.26

Shareholding Pattern

	MUTUAL FUNDS/UTI	7.13%
	PROMOTERS	47.68%
	NON-INSTITUTION	25.24%
	FI/BANKS/INSURANCE	1.13%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan Focused Fun...	4.13
Kotak Special Oppor...	3.75
Kotak Healthcare Fu...	3.26
Kotak Consumption F...	1.94
HDFC Pharma and Hea...	1.81
Kotak MNC Fund-Reg(G)	1.79

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

JUBILANT PHARMOVA LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES